BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 29544865)

  • 21. The relation of endocan and galectin-3 with ST-segment resolution in patients with ST-segment elevation myocardial infarction.
    Turan Y; Demir V
    Adv Clin Exp Med; 2020 Apr; 29(4):453-458. PubMed ID: 32343887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
    De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
    Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early ST-segment recovery after primary percutaneous coronary intervention accurately predicts long-term prognosis after acute myocardial infarction.
    Verouden NJ; Haeck JD; Kuijt WJ; Koch KT; Henriques JP; Baan J; Vis MM; Piek JJ; Tijssen JG; de Winter RJ
    Am Heart J; 2010 Jun; 159(6):1005-11. PubMed ID: 20569713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Outcome of Patients With ST-Segment Elevation Myocardial Infarction and Complete Versus Incomplete ST-Resolution Before Primary Percutaneous Coronary Intervention.
    Lønborg J; Kelbæk H; Holmvang L; Helqvist S; Vejlstrup N; Jørgensen E; Saunamäki K; Dridi NP; Kløvgaard L; Kaltoft A; Bøtker HE; Lassen JF; Clemmensen P; Terkelsen CJ; Engstrøm T
    Am J Cardiol; 2016 Jun; 117(11):1735-40. PubMed ID: 27062938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Ndrepepa G; Alger P; Kufner S; Mehilli J; Schömig A; Kastrati A
    Cardiol J; 2012; 19(1):61-9. PubMed ID: 22298169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Thrane PG; Kristensen SD; Olesen KKW; Mortensen LS; Bøtker HE; Thuesen L; Hansen HS; Abildgaard U; Engstrøm T; Andersen HR; Maeng M
    Eur Heart J; 2020 Feb; 41(7):847-854. PubMed ID: 31504424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial.
    Verardi FM; Bujak K; Tolomeo P; Gómez-Lara J; Jiménez-Díaz V; Jiménez M; Jiménez-Quevedo P; Diletti R; Bordes P; Campo G; Silvestro A; Maristany J; Flores X; de Miguel-Castro A; Íñiguez A; Ielasi A; Tespili M; Lenzen M; Gonzalo N; Tebaldi M; Biscaglia S; Vidal-Cales P; Ortega-Paz L; Romaguera R; Gómez-Hospital JA; Serruys PW; Sabaté M; Brugaletta S
    Rev Esp Cardiol (Engl Ed); 2024 Mar; 77(3):215-225. PubMed ID: 37506972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial.
    Regueiro A; Fernández-Rodríguez D; Brugaletta S; Martín-Yuste V; Masotti M; Freixa X; Cequier Á; Íñiguez A; Serruys PW; Sabaté M;
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):382-9. PubMed ID: 25444377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
    Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
    BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation.
    Moscarella E; Spitaleri G; Brugaletta S; Sentí Farrarons S; Pernigotti A; Ortega-Paz L; Cequier A; Iñiguez A; Serra A; Jiménez-Quevedo P; Mainar V; Campo G; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Valgimigli M; Serruys PW; Sabaté M
    Am J Cardiol; 2017 Nov; 120(9):1460-1466. PubMed ID: 28864322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
    Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
    JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction.
    McGehee JT; Rangasetty UC; Atar S; Barbagelata NN; Uretsky BF; Birnbaum Y
    J Electrocardiol; 2007 Jan; 40(1):26-33. PubMed ID: 17067628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry.
    Pimor A; Auffret V; Didier R; Delaunay R; Filippi E; Hacot JP; Saouli D; Rouault G; Druelles P; Bot E; Coudert I; Boulanger B; Le Guellec M; Boulmier D; Leurent G; Bedossa M; Gilard M; Le Breton H
    Arch Cardiovasc Dis; 2018 Nov; 111(11):656-665. PubMed ID: 29229216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
    Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
    Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.